US Stock MarketDetailed Quotes

Annovis Bio (ANVS)

Watchlist
  • 1.940
  • -0.110-5.37%
Close May 19 15:59 ET
  • 1.580
  • -0.360-18.56%
Pre 06:27 ET
67.21MMarket Cap-1.13P/E (TTM)

Annovis Bio (ANVS) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
-36.05%14.22M
85.11%19.53M
85.11%19.53M
20.97%15.29M
328.50%17.13M
608.84%22.24M
83.36%10.55M
83.36%10.55M
98.85%12.64M
-74.58%4M
-Cash and cash equivalents
-36.05%14.22M
85.11%19.53M
85.11%19.53M
20.97%15.29M
328.50%17.13M
608.84%22.24M
83.36%10.55M
83.36%10.55M
98.85%12.64M
-74.58%4M
Prepaid assets
-55.02%2.02M
-54.08%1.55M
-54.08%1.55M
10.30%1.9M
312.35%4.32M
-3.75%4.5M
-24.25%3.37M
-24.25%3.37M
-55.41%1.72M
-85.16%1.05M
Total current assets
-39.25%16.24M
51.39%21.08M
51.39%21.08M
19.69%17.19M
325.14%21.45M
242.20%26.74M
36.42%13.93M
36.42%13.93M
40.48%14.36M
-77.88%5.05M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-39.25%16.24M
51.39%21.08M
51.39%21.08M
19.69%17.19M
325.14%21.45M
242.20%26.74M
36.42%13.93M
36.42%13.93M
40.48%14.36M
-77.88%5.05M
Liabilities
Current liabilities
Payables
285.03%5.28M
12.34%2.59M
12.34%2.59M
-48.48%2.11M
-71.30%974.31K
-66.64%1.37M
78.37%2.31M
78.37%2.31M
112.80%4.1M
189.43%3.39M
-accounts payable
285.03%5.28M
12.34%2.59M
12.34%2.59M
-48.48%2.11M
-71.30%974.31K
-66.64%1.37M
78.37%2.31M
78.37%2.31M
112.80%4.1M
189.43%3.39M
Current accrued expenses
562.59%7.51M
-33.66%1.04M
-33.66%1.04M
25.53%1.62M
176.27%1.83M
48.61%1.13M
-47.26%1.58M
-47.26%1.58M
-21.15%1.29M
-26.45%662.68K
Current liabilities
410.73%12.79M
-6.33%3.64M
-6.33%3.64M
-30.75%3.73M
-30.86%2.81M
-48.58%2.5M
-9.30%3.88M
-9.30%3.88M
51.24%5.39M
95.64%4.06M
Non current liabilities
Derivative product liabilities
82.68%327K
-19.27%595K
-19.27%595K
-84.32%299K
-88.36%319K
-97.16%179K
-94.61%737K
-94.61%737K
--1.91M
--2.74M
Total non current liabilities
82.68%327K
-19.27%595K
-19.27%595K
-84.32%299K
-88.36%319K
-97.16%179K
-94.61%737K
-94.61%737K
--1.91M
--2.74M
Total liabilities
388.85%13.12M
-8.39%4.23M
-8.39%4.23M
-44.74%4.03M
-54.04%3.12M
-75.97%2.68M
-74.29%4.62M
-74.29%4.62M
104.71%7.3M
227.76%6.8M
Shareholders'equity
Share capital
46.51%2.85K
92.29%2.72K
92.29%2.72K
52.03%2.02K
66.21%1.95K
76.93%1.95K
34.41%1.41K
34.41%1.41K
47.23%1.33K
29.93%1.17K
-common stock
46.51%2.85K
92.29%2.72K
92.29%2.72K
52.03%2.02K
66.21%1.95K
76.93%1.95K
34.41%1.41K
34.41%1.41K
47.23%1.33K
29.93%1.17K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-29.15%-181.31M
-21.40%-163.7M
-21.40%-163.7M
-19.29%-153.87M
-26.01%-146.61M
-26.10%-140.39M
-22.30%-134.85M
-22.30%-134.85M
-46.50%-128.98M
-58.66%-116.35M
Paid-in capital
12.16%184.43M
25.25%180.55M
25.25%180.55M
22.77%167.02M
43.93%164.94M
52.30%164.44M
40.63%144.16M
40.63%144.16M
43.66%136.05M
21.82%114.59M
Total stockholders'equity
-87.00%3.13M
81.05%16.85M
81.05%16.85M
86.25%13.16M
1,146.93%18.33M
817.16%24.05M
220.09%9.31M
220.09%9.31M
6.09%7.06M
-108.44%-1.75M
Total equity
-87.00%3.13M
81.05%16.85M
81.05%16.85M
86.25%13.16M
1,146.93%18.33M
817.16%24.05M
220.09%9.31M
220.09%9.31M
6.09%7.06M
-108.44%-1.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments -36.05%14.22M85.11%19.53M85.11%19.53M20.97%15.29M328.50%17.13M608.84%22.24M83.36%10.55M83.36%10.55M98.85%12.64M-74.58%4M
-Cash and cash equivalents -36.05%14.22M85.11%19.53M85.11%19.53M20.97%15.29M328.50%17.13M608.84%22.24M83.36%10.55M83.36%10.55M98.85%12.64M-74.58%4M
Prepaid assets -55.02%2.02M-54.08%1.55M-54.08%1.55M10.30%1.9M312.35%4.32M-3.75%4.5M-24.25%3.37M-24.25%3.37M-55.41%1.72M-85.16%1.05M
Total current assets -39.25%16.24M51.39%21.08M51.39%21.08M19.69%17.19M325.14%21.45M242.20%26.74M36.42%13.93M36.42%13.93M40.48%14.36M-77.88%5.05M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -39.25%16.24M51.39%21.08M51.39%21.08M19.69%17.19M325.14%21.45M242.20%26.74M36.42%13.93M36.42%13.93M40.48%14.36M-77.88%5.05M
Liabilities
Current liabilities
Payables 285.03%5.28M12.34%2.59M12.34%2.59M-48.48%2.11M-71.30%974.31K-66.64%1.37M78.37%2.31M78.37%2.31M112.80%4.1M189.43%3.39M
-accounts payable 285.03%5.28M12.34%2.59M12.34%2.59M-48.48%2.11M-71.30%974.31K-66.64%1.37M78.37%2.31M78.37%2.31M112.80%4.1M189.43%3.39M
Current accrued expenses 562.59%7.51M-33.66%1.04M-33.66%1.04M25.53%1.62M176.27%1.83M48.61%1.13M-47.26%1.58M-47.26%1.58M-21.15%1.29M-26.45%662.68K
Current liabilities 410.73%12.79M-6.33%3.64M-6.33%3.64M-30.75%3.73M-30.86%2.81M-48.58%2.5M-9.30%3.88M-9.30%3.88M51.24%5.39M95.64%4.06M
Non current liabilities
Derivative product liabilities 82.68%327K-19.27%595K-19.27%595K-84.32%299K-88.36%319K-97.16%179K-94.61%737K-94.61%737K--1.91M--2.74M
Total non current liabilities 82.68%327K-19.27%595K-19.27%595K-84.32%299K-88.36%319K-97.16%179K-94.61%737K-94.61%737K--1.91M--2.74M
Total liabilities 388.85%13.12M-8.39%4.23M-8.39%4.23M-44.74%4.03M-54.04%3.12M-75.97%2.68M-74.29%4.62M-74.29%4.62M104.71%7.3M227.76%6.8M
Shareholders'equity
Share capital 46.51%2.85K92.29%2.72K92.29%2.72K52.03%2.02K66.21%1.95K76.93%1.95K34.41%1.41K34.41%1.41K47.23%1.33K29.93%1.17K
-common stock 46.51%2.85K92.29%2.72K92.29%2.72K52.03%2.02K66.21%1.95K76.93%1.95K34.41%1.41K34.41%1.41K47.23%1.33K29.93%1.17K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -29.15%-181.31M-21.40%-163.7M-21.40%-163.7M-19.29%-153.87M-26.01%-146.61M-26.10%-140.39M-22.30%-134.85M-22.30%-134.85M-46.50%-128.98M-58.66%-116.35M
Paid-in capital 12.16%184.43M25.25%180.55M25.25%180.55M22.77%167.02M43.93%164.94M52.30%164.44M40.63%144.16M40.63%144.16M43.66%136.05M21.82%114.59M
Total stockholders'equity -87.00%3.13M81.05%16.85M81.05%16.85M86.25%13.16M1,146.93%18.33M817.16%24.05M220.09%9.31M220.09%9.31M6.09%7.06M-108.44%-1.75M
Total equity -87.00%3.13M81.05%16.85M81.05%16.85M86.25%13.16M1,146.93%18.33M817.16%24.05M220.09%9.31M220.09%9.31M6.09%7.06M-108.44%-1.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S. Show More